IXICO plc (LON:IXI – Get Free Report) shares passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 7.64 and traded as high as GBX 8.73. IXICO shares last traded at GBX 8.73, with a volume of 6,798 shares.
IXICO Price Performance
The company has a debt-to-equity ratio of 5.22, a quick ratio of 4.90 and a current ratio of 2.83. The stock’s 50 day simple moving average is GBX 7.64 and its two-hundred day simple moving average is GBX 9.18. The firm has a market capitalization of £19.04 million, a PE ratio of -4.48, a price-to-earnings-growth ratio of -0.38 and a beta of 0.07.
IXICO (LON:IXI – Get Free Report) last released its earnings results on Tuesday, May 19th. The company reported GBX (1.21) earnings per share for the quarter. The business had revenue of GBX 395 million during the quarter. IXICO had a negative return on equity of 16.18% and a negative net margin of 24.98%. On average, sell-side analysts forecast that IXICO plc will post -289.3584879 EPS for the current year.
About IXICO
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Read More
- Five stocks we like better than IXICO
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
